Cannabis for the Prophylactic Treatment of Migraine

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

June 30, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions

Chronic Migraine

Interventions

DRUG

CBD 100 mg OD

CBD oil - purified to \<1% THC in soft-gel capsules

DRUG

CBD 200 mg OD

CBD oil - purified to \<1% THC in soft-gel capsules

DRUG

Placebo

Soft-gel capsules containing placebo

All Listed Sponsors

lead

University of Calgary

OTHER